Showing results (1711-1720 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|April 14, 2010
Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosisBasil S Pawlyk, Oleg V Bulgakov, Xiaoqing Liu, et al.Human Gene Therapy|April 14, 2010
Escherichia coli-cloned CFTR loci relevant for human artificial chromosome therapyLucia Rocchi, Carla Braz, Sonja Cattani, et al.Human Gene Therapy|April 14, 2010
Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modificationsSigrid Espenlaub, Stéphanie Corjon, Tatjana Engler, et al.Human Gene Therapy|May 8, 2009
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both gendersAstrid Pañeda, Lucia Vanrell, Itsaso Mauleon, et al.Human Gene Therapy|May 29, 2010
Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoproteinToshie Sakuma, Suk See De Ravin, Jason M Tonne, et al.Human Gene Therapy|September 16, 2006
Development of a synthetic promoter for macrophage gene therapyWeijing He, Mei Qiang, Wuqiong Ma, et al.Human Gene Therapy|May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutationColin J D Ross, Jaap Twisk, Andrew C Bakker, et al.Human Gene Therapy|May 24, 2006
Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene deliveryGrant Bledsoe, Bo Shen, Yuyu Yao, et al.Human Gene Therapy|May 24, 2006
CD46 represents a target for adenoviral gene therapy of malignant gliomaIlya V Ulasov, Matthew A Tyler, Sophy Zheng, et al.Human Gene Therapy|March 9, 2007
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brainJean-Marc Taymans, Luk H Vandenberghe, Chris Van Den Haute, et al.Pageof 414